메뉴 건너뛰기




Volumn 129, Issue 34-35, 2004, Pages 1808-1810

Diagnostic guidelines and conservative treatment of GIST;Diagnostik und konservative therapie gastrointestinaler stromatumoren

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

EID: 4444342939     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-829034     Document Type: Short Survey
Times cited : (4)

References (16)
  • 1
    • 0027257187 scopus 로고
    • Clinical applications of endoscopic ultrasonography in gastroenterology - State of the art, 1993: Results of a consensus conference, Orlando, Florida, 19 January 1993
    • Anononymus. Clinical applications of endoscopic ultrasonography in gastroenterology - state of the art, 1993: results of a consensus conference, Orlando, Florida, 19 January 1993. Endoscopy 1993; 25: 358-366
    • (1993) Endoscopy , vol.25 , pp. 358-366
  • 2
    • 0042978501 scopus 로고    scopus 로고
    • Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: A centre-based study of 17 patients
    • Brümming P, Andersson J, Meis-Kindblom JM et al. Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer 2003; 89: 460-464
    • (2003) Br J Cancer , vol.89 , pp. 460-464
    • Brümming, P.1    Andersson, J.2    Meis-Kindblom, J.M.3
  • 3
    • 0037103424 scopus 로고    scopus 로고
    • Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    • Demetri GD, Mehren Mvon, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472-480
    • (2002) N Engl J Med , vol.347 , pp. 472-480
    • Demetri, G.D.1    Mvon, M.2    Blanke, C.D.3
  • 4
    • 0032955439 scopus 로고    scopus 로고
    • Prognosis of gastrointestinal smooth-muscle (stromal) tumors. Dependence on anatomic site
    • Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors. Dependence on anatomic site. Am J Surg Pathol 1999; 23: 82-87
    • (1999) Am J Surg Pathol , vol.23 , pp. 82-87
    • Emory, T.S.1    Sobin, L.H.2    Lukes, L.3    Lee, D.H.4    O'Leary, T.J.5
  • 5
    • 0034254249 scopus 로고    scopus 로고
    • Inhibition of c-kit receptor tyrosine kinase activity by STI571, a selective tyrosine kinase inhibitor
    • Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Ziegler AJ. Inhibition of c-kit receptor tyrosine kinase activity by STI571, a selective tyrosine kinase inhibitor. Blood 2002; 96: 925-932
    • (2002) Blood , vol.96 , pp. 925-932
    • Heinrich, M.C.1    Griffith, D.J.2    Druker, B.J.3    Wait, C.L.4    Ott, K.A.5    Ziegler, A.J.6
  • 6
    • 15644363454 scopus 로고    scopus 로고
    • Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
    • Hirota S, Isozaki K, Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-580
    • (1998) Science , vol.279 , pp. 577-580
    • Hirota, S.1    Isozaki, K.2    Moriyama, Y.3
  • 7
    • 0035142836 scopus 로고    scopus 로고
    • Gastrointestinal stromal tumors - Definition, clinical, histological, immunhistochemical and molecular genetic features and differential diagnosis
    • Miettinen M, Lasota J. Gastrointestinal stromal tumors - definition, clinical, histological, immunhistochemical and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12
    • (2001) Virchows Arch , vol.438 , pp. 1-12
    • Miettinen, M.1    Lasota, J.2
  • 8
    • 0009882227 scopus 로고    scopus 로고
    • Specific EUS features can identify hypoechoic masses which are not benign stromal cell tumors
    • Nickl N, Behling C, McClave S. Specific EUS features can identify hypoechoic masses which are not benign stromal cell tumors (abstract). Gastrointest Endosc 1999; 49: AB211
    • (1999) Gastrointest Endosc , vol.49
    • Nickl, N.1    Behling, C.2    McClave, S.3
  • 9
    • 0033814350 scopus 로고    scopus 로고
    • Biological and clinical review of stromal tumors of the gastrointestinal tract
    • Nishida T, Hirota S. Biological and clinical review of stromal tumors of the gastrointestinal tract. Histol Histopathol 2000; 15: 1293-1301
    • (2000) Histol Histopathol , vol.15 , pp. 1293-1301
    • Nishida, T.1    Hirota, S.2
  • 11
    • 0346626792 scopus 로고    scopus 로고
    • Paradigmenwechsel in der Therapie gastrointestinaler Stromatumoren
    • Reichardt P, Pink D, Hohenberger P. Paradigmenwechsel in der Therapie gastrointestinaler Stromatumoren. Onkologe 2002; 8: 378-383
    • (2002) Onkologe , vol.8 , pp. 378-383
    • Reichardt, P.1    Pink, D.2    Hohenberger, P.3
  • 12
    • 0033847535 scopus 로고    scopus 로고
    • Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal
    • Robinson TL, Sircar K, Hewlett BR, Chorneyko K, Riddell RH, Huizinga JD. Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal. Am J Pathol 2000; 156: 1157-1163
    • (2000) Am J Pathol , vol.156 , pp. 1157-1163
    • Robinson, T.L.1    Sircar, K.2    Hewlett, B.R.3    Chorneyko, K.4    Riddell, R.H.5    Huizinga, J.D.6
  • 13
    • 0035960428 scopus 로고    scopus 로고
    • Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors: A phase I study
    • Van Oosterom AT, Judson I, Verweij J et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors: a phase I study. Lancet 2001; 358: 1421-1423
    • (2001) Lancet , vol.358 , pp. 1421-1423
    • Van Oosterom, A.T.1    Judson, I.2    Verweij, J.3
  • 14
    • 0242522370 scopus 로고    scopus 로고
    • Early efficacy comparison of two doses of imatinib for the treatment of advanced gastro-intestinal stromal tumors (GIST): Interim results of a randomized phase III trial from the EORTC-STBSG, ISG and AGITG
    • abstr 3272
    • Verweij J, Casali G, Zalcberg J et al. Early efficacy comparison of two doses of imatinib for the treatment of advanced gastro-intestinal stromal tumors (GIST): Interim results of a randomized phase III trial from the EORTC-STBSG, ISG and AGITG (abstr 3272). Proc Am Soc Clin Oncol 2003; 22: 814
    • (2003) Proc Am Soc Clin Oncol , vol.22 , pp. 814
    • Verweij, J.1    Casali, G.2    Zalcberg, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.